Cytokinetics, Incorporated

CYTK·NasdaqGS·Healthcare
Compare
62.79−0.12 (−0.19%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours62.790.00 (0.00%)Oct 12, 4:00 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close62.91
Open62.48
Day range62.1363.50
52-week range54.3088.31
Off day high−1.12%
Off 52-week high−28.90%
Volume1.25M
Avg. volume (3M)1.95M
Market cap8.73B
EPS (TTM)-7.22
Forward P/E-14.13
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.41
Shares outstanding139.02M
Short interest21.23% of float
Earnings dateNov 4, 2026
Analyst target109.95
Profit margin0.00%

Against its peers

Compare in full ›
CYTK EWTX SLDB SRRK BBIO BMRN
Market cap 8.73B 4.18B 719.48M 5.11B 12.85B 10.72B
P/E (TTM) — — — — — 149.7
Forward P/E -14.1 -21.2 -3.9 -16.6 2,275.1 8.3
Price/book -50.2 9.2 1.9 20.1 -5.1 1.7
Dividend yield — — — — — —
1-year change +2.88% +165.53% +14.31% +23.09% +16.37% +5.57%
Today −0.19% −1.56% −2.33% −0.59% +0.61% +1.09%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All CYTK news ›
Defense World·Positive

Analyzing Zai Lab (NASDAQ:ZLAB) and Cytokinetics (NASDAQ:CYTK)

Cytokinetics (NASDAQ:CYTK – Get Free Report) and Zai Lab (NASDAQ:ZLAB – Get Free Report) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their…

@gurufocus·Negative

Cytokinetics (CYTK) Launches ASPEN-HCM Study to Evaluate Myqorzo

The GF Score™ aggregates multiple fundamental factors to provide a snapshot of a company’s overall financial health, profitability, growth potential, valuation attractiveness, and market momentum. Cytokinetics’ GF Score™ of 57/100 reflects…

From articles in the 4Search news index.

In the news

5mentions in 30 days
5with it in the headline
Mixedsentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.